These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15025912)

  • 21. Identification and biological characterization of heterocyclic inhibitors of the hepatitis C virus RNA-dependent RNA polymerase.
    Dhanak D; Duffy KJ; Johnston VK; Lin-Goerke J; Darcy M; Shaw AN; Gu B; Silverman C; Gates AT; Nonnemacher MR; Earnshaw DL; Casper DJ; Kaura A; Baker A; Greenwood C; Gutshall LL; Maley D; DelVecchio A; Macarron R; Hofmann GA; Alnoah Z; Cheng HY; Chan G; Khandekar S; Keenan RM; Sarisky RT
    J Biol Chem; 2002 Oct; 277(41):38322-7. PubMed ID: 12167642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for Internal Initiation of RNA Synthesis by the Hepatitis C Virus RNA-Dependent RNA Polymerase NS5B
    Schult P; Nattermann M; Lauber C; Seitz S; Lohmann V
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31315989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of native hepatitis C virus replicase by nucleotide and non-nucleoside inhibitors.
    Ma H; Leveque V; De Witte A; Li W; Hendricks T; Clausen SM; Cammack N; Klumpp K
    Virology; 2005 Feb; 332(1):8-15. PubMed ID: 15661135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. De novo initiation of RNA synthesis by the RNA-dependent RNA polymerase (NS5B) of hepatitis C virus.
    Luo G; Hamatake RK; Mathis DM; Racela J; Rigat KL; Lemm J; Colonno RJ
    J Virol; 2000 Jan; 74(2):851-63. PubMed ID: 10623748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rate-limiting pyrophosphate release by hepatitis C virus polymerase NS5B improves fidelity.
    Villalba B; Johnson KA
    J Biol Chem; 2020 Nov; 295(48):16436-16444. PubMed ID: 32938715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HCV RNA-dependent RNA polymerase replicates in vitro the 3' terminal region of the minus-strand viral RNA more efficiently than the 3' terminal region of the plus RNA.
    Reigadas S; Ventura M; Sarih-Cottin L; Castroviejo M; Litvak S; Astier-Gin T
    Eur J Biochem; 2001 Nov; 268(22):5857-67. PubMed ID: 11722573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.
    Amin A; Zaccardi J; Mullen S; Olland S; Orlowski M; Feld B; Labonte P; Mak P
    Virology; 2003 Aug; 313(1):158-69. PubMed ID: 12951030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cooperation between the Hepatitis C Virus p7 and NS5B Proteins Enhances Virion Infectivity.
    Aligeti M; Roder A; Horner SM
    J Virol; 2015 Nov; 89(22):11523-33. PubMed ID: 26355084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C virus RNA-dependent RNA polymerase (NS5B polymerase).
    Hagedorn CH; van Beers EH; De Staercke C
    Curr Top Microbiol Immunol; 2000; 242():225-60. PubMed ID: 10592663
    [No Abstract]   [Full Text] [Related]  

  • 30. 1,5-benzodiazepines, a novel class of hepatitis C virus polymerase nonnucleoside inhibitors.
    Nyanguile O; Pauwels F; Van den Broeck W; Boutton CW; Quirynen L; Ivens T; van der Helm L; Vandercruyssen G; Mostmans W; Delouvroy F; Dehertogh P; Cummings MD; Bonfanti JF; Simmen KA; Raboisson P
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4420-31. PubMed ID: 18852280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Canonical 3'-deoxyribonucleotides as a chain terminator for HCV NS5B RNA-dependent RNA polymerase.
    Shim J; Larson G; Lai V; Naim S; Wu JZ
    Antiviral Res; 2003 May; 58(3):243-51. PubMed ID: 12767472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus.
    Behrens SE; Tomei L; De Francesco R
    EMBO J; 1996 Jan; 15(1):12-22. PubMed ID: 8598194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Slow binding inhibition and mechanism of resistance of non-nucleoside polymerase inhibitors of hepatitis C virus.
    Hang JQ; Yang Y; Harris SF; Leveque V; Whittington HJ; Rajyaguru S; Ao-Ieong G; McCown MF; Wong A; Giannetti AM; Le Pogam S; Talamás F; Cammack N; Nájera I; Klumpp K
    J Biol Chem; 2009 Jun; 284(23):15517-29. PubMed ID: 19246450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of soluble hepatitis C virus RNA-dependent RNA polymerase expressed in Escherichia coli.
    Ferrari E; Wright-Minogue J; Fang JW; Baroudy BM; Lau JY; Hong Z
    J Virol; 1999 Feb; 73(2):1649-54. PubMed ID: 9882374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of inhibition for BMS-791325, a novel non-nucleoside inhibitor of hepatitis C virus NS5B polymerase.
    Rigat KL; Lu H; Wang YK; Argyrou A; Fanslau C; Beno B; Wang Y; Marcinkeviciene J; Ding M; Gentles RG; Gao M; Abell LM; Roberts SB
    J Biol Chem; 2014 Nov; 289(48):33456-68. PubMed ID: 25301950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations in NS5B polymerase of hepatitis C virus: impacts on in vitro enzymatic activity and viral RNA replication in the subgenomic replicon cell culture.
    Cheney IW; Naim S; Lai VC; Dempsey S; Bellows D; Walker MP; Shim JH; Horscroft N; Hong Z; Zhong W
    Virology; 2002 Jun; 297(2):298-306. PubMed ID: 12083828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Silibinin and related compounds are direct inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
    Ahmed-Belkacem A; Ahnou N; Barbotte L; Wychowski C; Pallier C; Brillet R; Pohl RT; Pawlotsky JM
    Gastroenterology; 2010 Mar; 138(3):1112-22. PubMed ID: 19962982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. De novo initiation of RNA synthesis by hepatitis C virus nonstructural protein 5B polymerase.
    Zhong W; Uss AS; Ferrari E; Lau JY; Hong Z
    J Virol; 2000 Feb; 74(4):2017-22. PubMed ID: 10644375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ligand-induced changes in hepatitis C virus NS5B polymerase structure.
    Rigat K; Wang Y; Hudyma TW; Ding M; Zheng X; Gentles RG; Beno BR; Gao M; Roberts SB
    Antiviral Res; 2010 Nov; 88(2):197-206. PubMed ID: 20813137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The C-terminal transmembrane domain of hepatitis C virus (HCV) RNA polymerase is essential for HCV replication in vivo.
    Lee KJ; Choi J; Ou JH; Lai MM
    J Virol; 2004 Apr; 78(7):3797-802. PubMed ID: 15016899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.